Effects of blue light on inflammation and skin barrier recovery following acute perturbation. Pilot study results in healthy human subjects
Summary Background/purpose While growing evidence supports the therapeutic effect of 453 nm blue light in chronic inflammatory skin diseases, data on its effects on acutely perturbed human skin are scarce. In this study, we investigated the impact of 453 nm narrow‐band LED light on healthy skin foll...
Saved in:
Published in | Photodermatology, photoimmunology & photomedicine Vol. 34; no. 3; pp. 184 - 193 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.05.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Summary
Background/purpose
While growing evidence supports the therapeutic effect of 453 nm blue light in chronic inflammatory skin diseases, data on its effects on acutely perturbed human skin are scarce. In this study, we investigated the impact of 453 nm narrow‐band LED light on healthy skin following acute perturbation.
Methods
Tape stripping and histamine iontophoresis were performed on the forearm of 22 healthy volunteers on 2 consecutive weeks. In 1 week, challenges were followed by irradiation for 30 minutes. In the other week (control), no light was administered. Reactions were evaluated up to 72 hours thereafter by transepidermal water loss (TEWL), diffuse reflectance spectroscopy, and skin surface biomarkers.
Results
Skin barrier disruption resulted in upregulation of IL‐1α at 24 hours after tape stripping (P = .029). In contrast, irradiation abrogated this effect (P > .05). Irradiation also resulted in higher TEWL at 24 hours and in higher b* value at 72 hours after tape stripping compared to the control (P = .034 and P = .018, respectively). At 30 minutes following histamine iontophoresis and irradiation, a trend toward a higher a* value compared to the control was observed (P = .051).
Conclusion
We provide the first in vivo evidence that blue light at 453 nm exerts biological effects on acutely perturbed healthy human skin. |
---|---|
Bibliography: | Funding information The costs incurred by this study were paid by Philips Electronics Nederland BV. GO, FvA, and NU are employees of Philips Electronics Nederland BV and received a salary for this study. This study was performed according to the Investigation Agreement between Philips Electronics Nederland BV, acting through Philips Research (“Philips”), and Radboudumc Dermatologie BV (“Institution”). Philips acts as the sponsor of the Investigation and funds the work by reimbursing the Institution for all documented costs made during the study (incl. the salary of DF), in accordance with the cost estimates and up to the yearly maximum amounts. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23 |
ISSN: | 0905-4383 1600-0781 |
DOI: | 10.1111/phpp.12367 |